PRESS RELEASE published on 11/19/2024 at 07:30, 4 months 21 days ago Nicox Announces Publication of the Adaptive Design Period of the NCX 470 Mont Blanc Phase 3 Trial Nicox announces the publication of the adaptive design period of the NCX 470 Mont Blanc Phase 3 trial, selecting 0.1% concentration due to better intraocular pressure reduction and safety profile Phase 3 Trial Ophthalmology Nicox NCX 470 Adaptive Design
BRIEF published on 10/14/2024 at 07:35, 5 months 27 days ago Nicox and Soleus sign $16.5 million financing agreement Funding Nicox NCX 470 Soleus Capital VYZULTA
PRESS RELEASE published on 10/14/2024 at 07:30, 5 months 27 days ago Nicox and Soleus Sign $16.5 million Royalty and Equity Financing Nicox and Soleus sign $16.5 million royalty and equity financing agreement, reducing debt burden and financing into Q3 2025. Topline results expected in Q3 2025 for NCX 470 Denali Phase 3 trial Equity Financing Nicox NCX 470 Soleus Royalty
BRIEF published on 09/18/2024 at 07:35, 6 months 22 days ago Nicox Announces Approval of ZERVIATE in China China Ophthalmology Nicox ZERVIATE Ocumension
PRESS RELEASE published on 09/18/2024 at 07:30, 6 months 22 days ago Nicox Announces Approval of ZERVIATE in China Nicox announces approval of ZERVIATE in China by partner Ocumension Therapeutics for ocular itching, adding royalty revenue stream. Launch expected to boost market penetration China Approval Nicox ZERVIATE Ocular Itching
BRIEF published on 09/04/2024 at 07:35, 7 months 6 days ago Nicox Appoints Christine Placet as Director; Michele Garufi Retires from Board of Directors Board Of Directors Ophthalmology Christine Placet Nicox Michele Garufi
PRESS RELEASE published on 09/04/2024 at 07:30, 7 months 6 days ago Nicox Appoints Christine Placet to Board of Directors; Michele Garufi steps down from Board Nicox appoints Christine Placet to Board of Directors as Michele Garufi steps down after over 25 years. Entire Nicox Board renewed for strategic direction support Board Of Directors Biotech Industry Christine Placet Nicox Michele Garufi
BRIEF published on 07/19/2024 at 07:35, 8 months 22 days ago Nicox: Participation in upcoming conferences Conférences 2024 Investments Ophthalmology Nicox
PRESS RELEASE published on 07/19/2024 at 07:30, 8 months 22 days ago Nicox announces attendance at upcoming conferences Nicox announces attendance at upcoming international conferences, including H.C. Wainwright 4th Annual Ophthalmology Virtual Conference and AAO 2024 Clinical Development International Conférences Ophthalmology Nicox
BRIEF published on 07/18/2024 at 07:35, 8 months 23 days ago Nicox Provides Second Quarter 2024 Update Q2 2024 Financial Update Ophthalmology Nicox NCX 470
Published on 04/11/2025 at 02:40, 12 minutes ago McFarlane Lake Announces Closing of Final Tranche of Upsized $1.3 Million Private Placement Offering
Published on 04/11/2025 at 02:00, 52 minutes ago Battery X Metals Announces Formation of Critical Battery Metals Exploration Subsidiary and Expansion of Quebec Exploration Portfolio with Acquisition of 39 Additional Mineral Claims
Published on 04/11/2025 at 00:00, 2 hours 52 minutes ago Onco-Innovations’ Inka Health Publishes Roche-Sponsored Study Advancing Real-World Oncology Research
Published on 04/10/2025 at 23:00, 3 hours 52 minutes ago Highlander Silver Receives Conditional Approval to List on the TSX, Files Base Shelf Prospectus and Establishes ATM Program as Longer Term Financial Alternatives
Published on 04/10/2025 at 20:47, 6 hours 4 minutes ago EQS-Adhoc: Hinkel & Cie. GmbH: first creditors´meeting of the bond DE000A2AAPX4
Published on 04/10/2025 at 20:44, 6 hours 7 minutes ago EQS-Adhoc: artnet AG: artnet is in talks with two investors regarding a potential takeover offer
Published on 04/10/2025 at 19:00, 7 hours 52 minutes ago Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments
Published on 04/10/2025 at 18:57, 7 hours 54 minutes ago EQS-Adhoc: HAMBORNER REIT AG: Adjustment of dividend strategy
Published on 04/10/2025 at 17:45, 9 hours 7 minutes ago EURAZEO INVESTS IN EKOSCAN INTEGRITY, A LEADING GLOBAL PROVIDER OF ADVANCED NON-DESTRUCTIVE TESTING SOLUTIONS FOR CRITICAL INDUSTRIAL APPLICATIONS AND INFRASTRUCTURE
Published on 04/09/2025 at 18:59, 1 day 7 hours ago Description of the 2025-2026 Share Buyback Program
Published on 04/09/2025 at 18:57, 1 day 7 hours ago Minutes of the Combined General Meeting held on April 9, 2025
Published on 04/09/2025 at 17:45, 1 day 9 hours ago COGELEC : 2024 full-year results and Q1 2025 revenue.
